NPPB and congenital heart disease: The median NT-proBNP level was higher in the patients with congenital heart disease than in the patients without congenital heart disease, but this was not statistically significant (13,147.5 pg/mL vs. 6567.0 pg/mL; p = 0.05, Mann–Whitney U test).